doi: 10.1080/17460441.2023.2241366 [DOI] [PubMed] [Google Scholar] 266.Shi Y, Williamson G
Such haptenated proteins can disrupt protein folding or function and lead to direct toxicity, or can be recognized as non-self leading to immune-mediated toxicity (Tafazoli and OBrien, 2009
Compounding BPC-157: A regulatory loophole In a statement, Health Canada said BPC157 has not been authorized, its safety, efficacy, and quality have not been assessed and there is limited scientific evidence to support its use, including a lack of established human dosing protocols
Tosin reflected that there are still plenty of paths forward
2011 DOI: 10.1152/japplphysiol.00945.2010 PMID: 21030672 Read on PubMed Neural Regeneration Research Pentadecapeptide BPC 157 and the central nervous system Vukojevic J, Milavi M, Perovi D, et al